Rapport Therapeutics Inc (RAPP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | RAPP | FTRE | SANA | ||
| Company | Rapport Therapeutics Inc | Fortrea Holdings Inc | Sana Biotechnology Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 30.67 | 16.34 | 5.16 | ||
| High | 30.86 | 16.42 | 5.36 | ||
| Low | 29.64 | 15.40 | 5.05 | ||
| Latest | 30.00 | 15.65 | 5.30 | ||
| Change | -0.27 | -0.07 | +0.16 | ||
| % Change | -0.89% | -0.45% | +3.11% | ||
| Volume | 77,674 | 488,141 | 4,771,383 | ||
| 20-Day Average Volume | 358,910 | 1,351,840 | 5,213,478 | ||
| Previous Close | 30.27 | 15.72 | 5.14 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 28.28 | 13.04 | 4.23 | ||
| 20-Day Raw Stochastic | 87.17% | 82.56% | 92.06% | ||
| 20-Day Relative Strength | 58.90 | 68.87 | 59.67 | ||
| Weighted Alpha | +28.57 | +12.99 | +80.37 | ||
| Today's Opinion | 100% Buy | 100% Buy | 88% Buy | ||
| Previous Opinion | 100% Buy | 100% Buy | 88% Buy | ||
| Last Month's Opinion | 56% Buy | 88% Buy | 40% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.30% since 12/08/25 | +5.95% since 12/08/25 | +14.58% since 12/08/25 | ||
| Low | 27.81 on 12/10/25 | 14.02 on 12/10/25 | 4.25 on 12/10/25 | ||
| High | 31.00 on 12/09/25 | 16.94 on 12/11/25 | 5.35 on 12/15/25 | ||
| 1-Month | |||||
| %Chg | +23.39% since 11/14/25 | +50.43% since 11/14/25 | +32.96% since 11/14/25 | ||
| Low | 23.75 on 11/17/25 | 9.60 on 11/17/25 | 3.16 on 11/21/25 | ||
| High | 31.00 on 12/09/25 | 16.94 on 12/11/25 | 5.49 on 12/04/25 | ||
| 3-Month | |||||
| %Chg | +21.59% since 09/15/25 | +53.53% since 09/15/25 | +64.24% since 09/15/25 | ||
| Low | 23.75 on 11/17/25 | 8.31 on 09/30/25 | 2.93 on 09/22/25 | ||
| High | 31.00 on 12/09/25 | 16.94 on 12/11/25 | 6.55 on 10/15/25 | ||
| 6-Month | |||||
| %Chg | +168.72% since 06/13/25 | +164.97% since 06/13/25 | +104.83% since 06/13/25 | ||
| Low | 10.51 on 06/23/25 | 4.36 on 07/07/25 | 2.43 on 06/16/25 | ||
| High | 42.27 on 09/08/25 | 16.94 on 12/11/25 | 6.55 on 10/15/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 1,442,698 | 1,452,528 | 1,369,121 | ||
| Shares Outstanding, K | 47,661 | 92,400 | 266,366 | ||
| Annual Sales | 0 | 2,696,400,000 | 0 | ||
| Annual Net Income | -78,310,000 | -328,500,000 | -266,760,000 | ||
| Last Quarter Sales | 0 | 701,300,000 | 0 | ||
| Last Quarter Net Income | -26,930,000 | -15,900,000 | -42,150,000 | ||
| 60-Month Beta | 1.63 | 1.76 | 1.95 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.71 on 11/06/25 | 0.12 on 11/05/25 | -0.15 on 11/06/25 | ||
| Latest Earnings Date | 03/10/26 | 03/02/26 | 03/16/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 30.49 | 0.00 | ||